Trying to practice what I preach and finding time to exercise at #cmsc2023 between sessions ๐๐ช physical exercise has so many benefits for people with (and without!) MS ๐งก
#CMSC2023 Dr. Jennifer Graves (UC San Diego) Exercise and physical activity are key to managing people aging with MS โ โone of the best fountains of youth that we have.โ
Learn more about exercise and Physical Activity Recommendations for people with MS: ntlms.org/recommendations.
We're excited for 1st yr neuroimmunology-neurological infectious disease fellow, Dr. Samantha Roman (@SamRomanMD) who's presenting 2 posters at #AANAM: 1st is tomorrow (4/23) about Stiff Person Syndrome (# 5-021) & 2nd on 4/26 about autoimmune encephalitis (#3-005)
What a fantastic week of learning and networking at my first ACTRIMS Forum & Advanced Curriculum. Itโs an added bonus when you get to work and travel with friends (and make new ones) ๐ค
@drmystimd @ShuvroRoy @alexsimpsonmd@EmilySchorrMD@drgillyweed@SachinGadani @agfilippatou
#ACTRIMSForum 2023 is a wrap! This year's "MS: Going Viral" theme attracted record-breaking attendees, residents, abstract submissions and industry support. A huge thank you to our 1800 registrants and speakers!
Amazing work by Thomas Garton from Johns Hopkins, bringing together lymphocyte, microglia, astrocyte pathology and synaptic pruning in the optic nerve at #ACTRIMS#ACTRIMS2023#C3
#ACTRIMSForum Dr. Tiffany Braley (U Michigan): cognitive behavioral therapy via telephone, modafinil, and combo of both all lessened MS fatigue in study funded by PCORI and National MS Society.
๐ntlms.org/3XXeEZJ
So much excellent learning this week at #ACTRIMSForum and the preceding Advanced Curriculum. One of the most shocking things I learned this week was that neuroimmunology may bring in as much revenue for a hospital as neurosurgery! ๐คฏ
Dr. Dimitrios Ladakis presenting a poster on macrophage migration inhibitory factor (MIF) as a possible predictor of brain atrophy in people with primary progressive MS.
#ACTRIMS2023#HopkinsMSCenter
Dr. Bou Rjeily presenting data on clinical and radiological disease activity for patients on standard and extended interval dosing with ocrelizumab.
#ACTRIMS2023#WomenInNeurology#HopkinsMSCenter
Dr. Schorr discussing how serum GFAP may represent a biomarker of cord atrophy and progression, as levels correlate with decreased spinal cord volume in patients with primary progressive MS.
@EmilySchorrMD#ACTRIMS2023#WomenInNeurology#HopkinsMSCenter